Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 13, 1999

View Archived Issues

New European Commission Structure Leaves Questions

U.S. FDA Gives First-Ever Approval To Proneuron For Spinal Cord Cell Therapy Test

UK Researchers Show Drug Reduces Tumor Blood Flow

Trials Begin For Bayer's 1st German Biotech Product

Chemunex Launches New Test For E. Coli In Drinking Water

Focus On New Peptide Could Herald Lifetime Flu Vaccine

NicOx Launches $34M IPO To Speed Up Its R&D Efforts

MediGene In-Licenses Its Phase II-Ready CHF Drug

Alchemia To Build Pilot Plant For Carbohydrate Production

Genetically Modified Tomato Gets 'Amber Light' From EU

Other News To Note

European Biotech Community Denounces

Inpharmatica Unveils Database On Structure-Function Relationships

VitaResc Extends Product Pipeline With SIRS Drug

Genset Finds Schizophrenia Gene Through Janssen Collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...